Quest's Focus Dx Business Gets FDA OK, CE Mark for Flu A/B and RSV Test on 3M Cycler
December 02, 2010
Quest's Focus Dx Business Gets FDA OK, CE Mark for Flu A/B and RSV Test on 3M Cycler
Quest Diagnostics has received 510(k) clearance from the US Food and Drug Administration for its Focus Diagnostics Simplexa Flu A/B and RSV test on the 3M Integrated Cycler.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Quest's Focus Diagnostics Launches Nucleic Acid Extraction-Free Flu/RSV Test in Europe
November 3, 2011 / PCR Insider - Focus Diagnostics Awaits CE Mark, FDA Clearance for Combined Flu/RSV Test on 3M Instrument
August 26, 2010 / PCR Insider - FDA Clears Focus Diagnostics' Flu Test on 3M Integrated Cycler
October 9, 2012 / GenomeWeb Daily News - PCR Probe Licensing Pact with Focus Diagnostics Portends 'Busy Year' for Evogen
March 14, 2013 / PCR Insider - Quest's Goal of Shifting Some MDx Testing to Hospital Labs Gains Momentum
April 28, 2011 / The Sample